Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 40,395,508
  • Shares Outstanding, K 1,372,130
  • Annual Sales, $ 8,386 M
  • Annual Income, $ 347,000 K
  • 36-Month Beta 1.09
  • Price/Sales 4.81
  • Price/Cash Flow 16.98
  • Price/Book 5.57

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.51 +2.28%
on 09/22/17
29.54 -1.29%
on 10/09/17
+0.23 (+0.80%)
since 09/15/17
3-Month
26.23 +11.19%
on 08/10/17
29.54 -1.29%
on 10/09/17
+1.38 (+4.97%)
since 07/14/17
52-Week
19.67 +48.25%
on 12/01/16
29.54 -1.29%
on 10/09/17
+6.21 (+27.06%)
since 10/14/16

Most Recent Stories

More News
Shifamed LLC Announces Completed Acquisition of Apama Medical

Shifamed LLC, a privately held medical device incubator, announced that Apama Medical, Inc., a Shifamed Portfolio Company, was acquired by Boston Scientific Corporation (NYSE: BSX) for $175 million in...

BSX : 29.16 (-0.95%)
MedTech Players Eyeing Emerging Market Growth Opportunities

The gloomy eco-political scenario in the United States and Europe points toward the fact that emerging geographies are playing a crucial role in the growth of the MedTech space globally.

ABT : 54.63 (-0.04%)
BSX : 29.16 (-0.95%)
JNJ : 136.12 (-0.23%)
TMO : 191.28 (-0.59%)
MDT : 77.73 (-0.44%)
Global Remote Patient Monitoring Market 2017-2021 with Medtronic, Boston Scientific, Abbott, Koninklijke Philips & GE Healthcare Dominating

DUBLIN, October 10, 2017 /PRNewswire/ --

BSX : 29.16 (-0.95%)
Breakfast Technical Briefing on Medical Equipment Stocks -- Abbott Laboratories, Boston Scientific, Edwards Lifesciences, and Medtronic

If you want a Stock Review on ABT, BSX, EW, or MDT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Medical Appliances and Equipment companies engage...

EW : 108.52 (+0.25%)
ABT : 54.63 (-0.04%)
BSX : 29.16 (-0.95%)
MDT : 77.73 (-0.44%)
Boston Scientific Grows on New Products, Currency Woe Ails

Boston Scientific (BSX) is gaining traction on product launch and accretive acquisitions. Yet an unfavorable currency movement is a major dampener.

OFIX : 48.79 (+0.47%)
BSX : 29.16 (-0.95%)
TMO : 191.28 (-0.59%)
IDXX : 158.55 (-0.66%)
Global Nitinol-based Medical Devices Market 2017-2021: Key Vendors are Abbott, Boston Scientific, Medtronic & Terumo

DUBLIN, Oct. 04, 2017 /PRNewswire/ --

BSX : 29.16 (-0.95%)
MDT : 77.73 (-0.44%)
Global Nitinol-based Medical Devices Market 2017-2021: Key Vendors are Abbott, Boston Scientific, Medtronic & Terumo

The "Global Nitinol-based Medical Devices Market 2017-2021" report has been added to Research and Markets' offering.

BSX : 29.16 (-0.95%)
MDT : 77.73 (-0.44%)
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary

Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Desiree Ralls-Morrison as senior vice president, general counsel and corporate secretary. Ralls-Morrison will join Boston Scientific...

BSX : 29.16 (-0.95%)
Boston Scientific's Apama Deal to Boost Electrophysiology Arm

Boston Scientific's (BSX) Apama Medical addition is expected to strengthen its suite of arrhythmia solutions under the Electrophysiology sub-segment.

OFIX : 48.79 (+0.47%)
BSX : 29.16 (-0.95%)
LMNX : 20.42 (-0.63%)
IDXX : 158.55 (-0.66%)
Boston Scientific Announces Agreement to Acquire Apama Medical

Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter...

BSX : 29.16 (-0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary...

See More

Support & Resistance

2nd Resistance Point 29.66
1st Resistance Point 29.41
Last Price 29.16
1st Support Level 29.00
2nd Support Level 28.84

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart